Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Primary sequence alterations and significant copy number changes for components of the (a) RTK/RAS/PI-3K, (b) p53, and (c) RB signaling pathways are shown. Red indicates activating genetic alterations, with frequently altered genes showing deeper shades of red. Conversely, blue indicates inactivating alterations, with darker shades corresponding to a higher percentage of alteration. For each altered component of a particular pathway, the nature of the alteration and the percentage of affected tumors affected are indicated. Blue boxes contain the final percentages of glioblastomas with alterations in at least one known component gene of the designated pathway.
Publication
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. (2008) . Nature. 2008 Oct 23;455(7216):1061-1068. Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | ERBB2 | ERBB2 | ncbigene_symbol | ERBB2 | 2064 |
| Homo sapiens | Primates | PDGFRA | PDGFRA | ncbigene_symbol | PDGFRA | 5156 |
| Homo sapiens | Primates | RTK/RAS/PI-3K | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RTK/RAS/PI-3K | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RTK/RAS/PI-3K | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | PI-3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI-3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI-3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI-3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI-3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI-3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI-3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI-3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI-3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI-3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | NF1 | NF1 | ncbigene_symbol | NF1 | 4763 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO1 | 2308 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO3 | 2309 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO4 | 4303 |
| Homo sapiens | Primates | FOXO | FOXO | famplex_relations | FOXO6 | 100132074 |
| Homo sapiens | Primates | P53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | P53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | P53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | CDKN2A | CDKN2A | ncbigene_symbol | CDKN2A | 1029 |
| Homo sapiens | Primates | CDKN2B | CDKN2B | ncbigene_symbol | CDKN2B | 1030 |
| Homo sapiens | Primates | CDKN2C | CDKN2C | ncbigene_symbol | CDKN2C | 1031 |
| Homo sapiens | Primates | CDK4 | CDK4 | ncbigene_symbol | CDK4 | 1019 |
| Homo sapiens | Primates | CCND2 | CCND2 | ncbigene_symbol | CCND2 | 894 |
| Homo sapiens | Primates | CDK6 | CDK6 | ncbigene_symbol | CDK6 | 1021 |
| Homo sapiens | Primates | MDM2 | MDM2 | ncbigene_symbol | MDM2 | 4193 |
| Homo sapiens | Primates | MDM4 | MDM4 | ncbigene_symbol | MDM4 | 4194 |
| Homo sapiens | Primates | RB1 | RB1 | ncbigene_symbol | RB1 | 5925 |
| Homo sapiens | Primates | RB1 | RB1 | ncbigene_synonym | RBM45 | 129831 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA | |||
| Lung cancer | NA |